Failed treatment of pseudomyxoma peritonei (PMP) with intraperitoneal interferon alpha.
Maiche
A G
AG
Helsinki University Central Hospital, Department of Oncology, Finland.
Sjöström
J
J
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009232:Myxoma / Q000188:drug therapy*; D010529:Peritoneal Cavity; D010534:Peritoneal Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D016898:Interferon-alpha